Guía de Práctica Clínica sobre Lupus Eritematoso Sistémico

189 Cervera R, Vinas O, Ramos-Casals M, Font J, García-Carrasco M, Sisó A et al. Antichromatin
antibodies in systemic lupus erythematosus: a useful marker for lupus
nephropathy. Ann Rh 2003; 62: 431–434.
190 Bose N, Wang X, Gupta M, Yao Q. The clinical utility of anti-chromatin antibodies as
measured by BioPlex 2200 in the diagnosis of systemic lupus erythematosus versus other
rheumatic. Int J Clin Exp Med 2012; 5: 316–320.
191 Gutiérrez-Adrianzén O. Diagnostic value of anti-nucleosome antibodies in the assessment
of disease activity of systemic lupus erythematosus: a prospective study comparing anti-. J
Rheumatol 2006; 33: 1538–1544.
192 Bonfa E, Golombek S, Kaufman L, Skelly S, Weissbach H, Brot N et al. Association
between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 1987; 317:
265–271.
193 Hanly JG, Urowitz MB, Su L, Bae S-C, Gordon C, Clarke A et al. Autoantibodies as
biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus.
Ann Rheum Dis 2011; 70: 1726–1732.
194 Hanly JG, Urowitz MB, Siannis F, Farewell V, Gordon C, Bae SC et al. Autoantibodies
and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results
from an international inception cohort study. Arthritis Rheum 2008; 58: 843–853.
195 Haddouk S, Marzouk S, Jallouli M, Fourati H, Frigui M, Hmida YBH et al. Clinical and
diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus.
Rheumatology 2009; 48: 953–957.
196 Gerli R, Caponi L, Tincani A, Scorza R, Sabbadini MG, Danieli MG et al. Clinical and
serological associations of ribosomal P autoantibodies in systemic lupus erythematosus :
prospective evaluation in a large cohort of Italian patients. Rheumatology 2002; 41: 1357–
1366.
197 Watanabe T, Sato T, Uchiumi T, Arakawa M. Neuropsychiatric manifestations in patients
with systemic lupus erythematosus: diagnostic and predictive value of longitudinal
examination of anti-ribosomal P. Lupus 1996; 5: 178–183.
198 Tzioufas AG, Tzortzakis NG, Boki KA, Sakarellos C, Moutsopoulos HM. The clinical
relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus
erythematosus populations : a large cohort of consecutive patients and patients with
active central nervous system disease. Ann Rheum Dis 2000; 59: 99–104.
199 Massardo L, Burgos P, Martinez M, Perez R, Calvo M, Barros J et al. Antiribosomal P
protein antibodies in Chilean SLE patients: no association with renal disease. Lupus 2002;
11: 379–383.
200 Karassa FB, Afeltra A, Ambrozic A, Chang D-M, De Keyser F, Doria A et al. Accuracy
of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic
lupus erythematosus: an international meta-analysis. Arthritis Rheum 2006; 54: 312–324.
201 West SG, Emlen W, Wener MH, Kotzin BL. Prospective Study on the Value of Diagnostic
Tests. Am J Med 1995; 99: 153–163.
GUÍA DE PRÁCTICA CLÍNICA SOBRE LUPUS ERITEMATOSO SISTÉMICO 449